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Abstract In vitro studies with smooth muscle cells from rat
aorta and dog cerebral blood vessels indicate that variation in
free Mg2+, within the pathophysiological range of Mg2+
concentrations, found in human serum, causes sustained changes
in membrane phospholipids and lipid second messengers.
Incorporation of [3H]palmitic acid into phosphatidylcholine
(PC) and sphingomyelin (SM) was altered within 15^30 min
after modifying the extracellular Mg2+ ion level ([Mg2+]o).
Decreased Mg2+ produced a fall in both [3H]SM and [3H]PC
over the first 2 h. After an 18-h incubation, the [3H]PC/[3H]SM
ratio changed from about 20:1 to about 50:1. Increased [Mg2+]o
resulted in a 2- to 3-fold increase in [3H]SM compared to only a
small increase in [3H]PC over the same period. There was a
reciprocal relationship between [3H]ceramide and [3H]1,2-DAG
levels with highest [3H]ceramide and lowest [3H]-1,2-DAG levels
seen at lowest [Mg2+]o. The results indicate that a fall in
extracellular ionized Mg2+ concentration produces a rapid and
sustained decrease in membrane sphingomyelin and a moderate
rise in intracellular ceramide. A major effect of lowering [Mg2+]o
appears to be a down-regulation of SM synthase. The increased
membrane SM content and a concomitant decrease in cell
ceramide, in the presence of elevated [Mg2+]o, may be relevant to
the apparent protective role of adequate Mg intake on vascular
function in humans.
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1. Introduction
Both animal and human studies indicate a statistical rela-
tionship between a reduced dietary intake of magnesium and
cardiovascular disease [1^6]. It is known that the responsive-
ness of vascular smooth muscle to contractile stimuli in vitro
is increased as extracellular ionized Mg2 ([Mg2]o) is low-
ered. Conversely, increased [Mg2]o relaxes vascular smooth
muscle and improves cardiovascular performance [7,8]. These
observations, plus clinical data indicating that patients pre-
senting with severe cardiovascular problems frequently have
low serum [Mg2]o [9,10], have formed the rationale for the
therapeutic administration of Mg salts [6,11].
The range for total blood Mg in healthy human subjects
extends from 0.70 to 0.96 mM but concentrations of free ion-
ized Mg2 in humans and many mammals [12] average about
0.6 mM, and the normal range is only about 0.54^0.65 mM
[9,13]. Physiological e¡ects of Mg de¢ciency can be fully ex-
plained only by identifying metabolic pathways that are par-
ticulary sensitive to small reductions in [Mg2]o ; large reduc-
tions would obviously cause widespread damage by
downregulating a multitude of biochemical pathways which
require Mg2 as a cofactor.
We have previously shown that as [Mg2]o is lowered with-
in the pathophysiological range found in human serum (0.3^
0.54 mM), fatty acid chain length and double bond content
are progressively reduced in aortic and cerebrovascular
smooth muscle lipids, indicating peroxidative degradation of
fatty acid double bonds and truncation of the fatty acids in
the sn-2 (middle carbon of glycerol) position [14,15]. We have
now measured the uptake of [3H]palmitic acid into the major
phospholipid fractions of vascular smooth muscle as a func-
tion of [Mg2]o. Palmitic acid (C 16:0) is the predominant
fatty acid moiety in most mammalian sphingomyelin and a
common fatty acid in the sn-1 position (outer carbon of the
glycerol moiety) of most phospholipids (reviewed in [16]). We
¢nd that turnover of all the phospholipids increases when
[Mg2]o levels are above 0.6 mM, and decreases when levels
are below 0.6 mM. The greatest decrease is seen in sphingo-
myelin (SM), a¡ecting the turnover of two lipid second mes-
sengers, ceramide and 1,2-diacylglycerol (1,2-DAG) which are
related to SM synthesis.
The metabolic interrelationships between phosphatidylcho-
line (PC), SM, 1,2-DAG and ceramide are reviewed in [16,17].
SM synthesis, catalyzed by SM synthase, requires transfer of a
choline phosphate moiety from PC to ceramide, generating
1,2-DAG. Conversely, sphingomyelinase (SMase) regenerates
ceramide and choline phosphate. Our experiments indicate
that as [Mg2]o is lowered from 0.6 mM to 0.3 mM (the
pathophysiological range), the ratio of PC to SM nearly dou-
bles ; ceramide labeling increases, 1,2-DAG labeling falls. This
indicates that low serum ionized Mg2 may inhibit the syn-
thesis of sphingomyelin.
2. Materials and methods
2.1. Materials
Phospholipid standards were obtained from Sigma, St. Louis, MO,
USA, [9,10-3H(N)]palmitic acid (60 Ci/mmol) from Amersham, Ar-
lington Heights, IL, USA, and aminopropylsilyl minicolumns from
Altec, Deer¢eld, IL, USA.
2.2. Tissue preparation and incubation
Adult male Wistar rats (16^20 weeks old, 275^325 g) were killed by
decapitation and exsanguinated. Thoracic aortae were excised, imme-
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diately placed in normal Krebs-Ringer bicarbonate (NKRB) solution
at room temperature, cleaned of blood, loose connective tissue and
fat, and the aortae cut into rings about 2^3 mm long [18]. Endothelial
cells were rubbed o¡ with wet ¢lter paper. NKRB composition was
(in mM): NaCl 118, KCl 4.7, KHPO4 1.2, MgSO4 1.2, CaCl2 2.5,
glucose 10 and NaHCO3 25. Concentrations of ionized Mg2 in cul-
ture media were determined using an ion selective electrode (NOVA
Biomedical, MA, USA) [9].
Male mongrel dogs (15 þ 3 kg) were anesthetized with sodium pen-
tobarbital (40 mg/kg, i.v.) and sacri¢ced by bleeding from the com-
mon femoral arteries. After craniotomy the brains were rapidly re-
moved, placed in normal Krebs-Ringer bicarbonate solution (NKRB)
at room temperature and basilar and middle cerebral arteries excised
and cleaned of arachnoid membranes and blood elements. The vessels
were cut into segments about 3^4 mm in length [19]. Control experi-
ments showed that cerebrovascular or aortic smooth muscle tissue
denuded of endothelial cells maintain normal ion gradients, a normal
response to contractile stimuli and exclude trypan blue for at least 36 h
under these conditions.
2.3. Incubation of tissue in 3H-labeled medium
Up to 50 mg wet weight of tissue was incubated in 10 ml of NKRB
solution containing [3H]palmitic acid (4^20 WCi/ml) at 37‡C for 3 h,
rinsed with fresh NKRB solution and transferred to NKRB contain-
ing the Mg2 concentrations described below. Isotope concentration
in the medium was not rate-limiting and was used without carrier
addition.
2.4. Primary culture of vascular smooth muscle cells
Aortic smooth muscle cells from adult Wistar rats (200^250 g) were
isolated according to previous established methods and cultured in
Dulbecco’s modi¢ed Eagle’s medium at 37‡C in a humidi¢ed atmos-
phere composed of 95% air-5% CO2 [20]. Coverslips containing a
monolayer of primary cultured cells were labeled with [3H]palmitic
acid containing culture medium for 3 h under 95% air-5% CO2. The
labeled cells were washed for 5 min with unlabeled medium, trans-
ferred to culture medium containing di¡ering [Mg2]o and incubated
for 18 h under 95% air-5% CO2.
2.5. Extraction of diacylglycerol and ceramide
Lipid extraction was performed using a modi¢cation of the proce-
dure of Bocckino et al. [21]. Tissue samples were homogenized in
4 volumes of chloroform/methanol (1:2, v/v). Suspensions were quan-
titatively transferred to 15 ml glass-stoppered centrifuge tubes, using
successive 0.3-ml aliquots of water and chloroform to rinse the ho-
mogenizer. The suspension was vortexed for 1 min, and centrifuged at
2000Ug for 5 min. Upper aqueous and lower lipid-containing phases
were separated, the interfacial material washed twice with 0.35 ml
volumes of chloroform and the upper and lower phases separated
and pooled with the ¢rst fractions. The lower chloroform phase was
washed twice with fresh upper phase and taken to dryness under N2.
Crude lipids were dissolved in hexane and applied to aminopropylsilyl
minicolumns and the neutral lipids, free fatty acids and N-containing
phospholipids eluted successively with chloroform, methanol and
ethanol. Lipids were stored in chloroform containing 0.05% BHT at
335‡C under N2.
2.6. Phospholipid analysis
Sphingomyelin, phosphatidylethanolamine, phosphatidylinositol
and phosphatidylcholine in the lipid extracts were separated by
TLC using LK5 silica gel 150A plates (Whatman Laboratory Divi-
sion, Clifton, NJ, USA) and developed with CHCl3/ethanol/water/tet-
raethylammonium (30:34:8:35, v/v) as described by Touchstone et al.
[22], or by the two-dimensional system of Skidmore and Entemann
[23]. Ceramide was separated on silica gel H plates (Analtech, New-
ark, DE, USA) and developed in diethylether/methyl alcohol (99:2).
1,2-DAG was separated on silica gel G plates developed in a solvent
system of toluene/diethyl ether/ethanol/ammonium hydroxide
(50:40:2:0.2, v/v). Lipids were visualized with I2 vapor, scraped
from the plate, and either transferred directly to counting vials con-
taining BCS scintillant (Amersham, Arlington Heights, IL, USA) or
eluted with chloroform/methanol (2:1) and aliquots counted in a
Beckman LS 7500 Liquid Scintillation System. Sonication for 1 min
facilitated extraction into the BCS scintillant. Recovery of total dpm
applied to the TLC plates was greater than 96%.
2.7. Total lipid analysis by 1H-NMR
1H-NMR spectra were obtained on a Varian VXR-500 spectrom-
eter, as previously described [14,15]. Total phospholipid content of
tissue and cell extracts was determined using resonances unique to
lipids [24].
Where appropriate, means þ SD were calculated and examined for
statistical signi¢cance by means of ANOVA. Values of P6 0.05 were
considered to be statistically signi¢cant.
3. Results
3.1. Low [Mg2+]o changes membrane phospholipid and lipid
second messenger turnover in vascular smooth muscle cells
within minutes
Segments of cerebrovascular smooth muscle tissue, denuded
of endothelial cells, were preincubated in NKRB solution con-
taining 0.6 mM ionized Mg2 plus [3H]palmitic acid for 3 h at
37‡C. About 25% of the total labeled palmitic acid taken up
into the tissue was recovered in the free fatty acid pool. For
comparison, about 45% was recovered in the neutral lipid
fraction (triglyceride, 1,2-DAG, ceramide) and about 25%
was taken up into the basic phospholipids (PC, phosphatidyl-
ethanolamine (PE), SM). Only about 5% of the total palmitic
acid-derived label was recovered in the acidic phospholipid
fraction (phosphatidylinositol (PI), phosphatidic acid).
After a 3-h uptake period in 0.6 mM [Mg2]o and
[3H]palmitate, cerebrovascular smooth muscle segments
pooled from 4 dogs were rinsed in fresh NKRB containing
0.6 mM [Mg2]o and transferred to palmitate-free NKRB
containing either low (0.17 mM) or elevated (1 2 mM)
[Mg2]o. Fig. 1A compares the changes in [3H]phosphatidyl-
choline (PC) as a function of time during the 2-h period fol-
lowing transfer. 3H-labeled PC decreased by about 25% fol-
lowing transfer to low (0.17 mM) [Mg2]o whereas a slight rise
in 3H-labeled PC occurred following transfer to elevated
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Table 1
[3H]Palmitic acid incorporationa into rat aortic smooth muscle cell lipids as a function of extracellular Mg2 ([Mg2]o) during an 18-h
incubation period
Mg2 statusb Mg2 (mM) PC SM PE PI
Low 0.17 754 (83%) 14.6 (1.7%) 41.1 (4.5%) 2.40 (0.27%)
Normal 0.6 848 (80%) 35.8 (3.3%) 60.1 (5.7%) 6.70 (0.63%)
High 1.2 958 (79%) 45.6 (3.7%) 75.1 (6.2%) 8.20 (0.67%)
Mg2 therapy dosage 4.8 1007 (76%) 57.0 (4.4%) 91.1 (6.9%) 18.9 (1.4%)
adpm per mg tissue wet wt. 64, 75, 86 and 93% of the total labeled palmitate taken up into the tissue was recovered in the lipid-bound fraction in
0.17, 0.6, 1.2 and 4.8 mM [Mg2]o, respectively. The increasing lipid incorporation of radioactivity from palmitate re£ects increased incorporation
of this fatty acid into lipids with increasing [Mg2]o. The numbers in parentheses refer to % of lipid-bound radioactivity; these account for
approximately 90% of the total lipid-bound radioactivity. The remainder, approximately 10% of the lipid-bound activity, was resident in compo-
nents not assayed here.
bRelative to human serum ionized Mg2 levels.
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(1.2 mM) [Mg2]o. As shown in Fig. 1B, sphingomyelin (SM)
labeling in the same samples also decreased by about 25%
over the ¢rst 2 h in low [Mg2]o but increased 2^3-fold over
the same time period after transfer to elevated [Mg2]o. A
similar time course of PC and SM labeling was seen for rat
aortic smooth muscle cells in culture (data not shown).
3.2. Prolonged exposure to elevated or lowered [Mg2+]o
results in marked changes in membrane lipid composition
Rat aortic smooth muscle cells were preincubated in NKRB
solution containing physiological levels (0.6 mM) of Mg2
plus [3H]palmitic acid for 3 h at 37‡C. The tissue was then
rinsed in fresh NKRB for a few minutes, and transferred to
NKRB solutions containing 0.17, 0.6, 1.2 or 4.8 mM Mg2
for 18 h at 37‡C. At the end of an 18-h incubation period, the
tissue was removed and the total lipids extracted. Table 1
illustrates [3H]palmitic acid incorporation into PC, SM, PE
and PI as a function of [Mg2]o. The total lipid-bound radio-
activity varied with the concentration of [Mg2]o and was in
the range of 64^93% of the total labeled palmitate taken up
into the tissue. About 80% of the total phospholipid counts
were recovered in the PC fraction, and about 10% in the PE
and SM fractions. The remainder, approximately 10% of lip-
id-bound activity, was resident in components not assayed in
this study. Less than 1% of the phospholipid-associated
[3H]palmitate was recovered with the PI fraction, probably
because PI often contains almost exclusively stearic acid in
the sn-1 position and arachidonic acid in the sn-2 position.
Thus, the [3H]palmitic acid labeling protocol used here is
probably not the best choice for labeling PI. Counts also
migrated with phosphatidylmonomethylethanolamine, phos-
phatidyldimethylethanolamine and phosphatidylglycerol.
Minimal counts were recovered with the phosphatidylserine
component on TLC.
[3H]Palmitic acid incorporation decreased in the four major
classes of phospholipids with decreasing extracellular Mg2
concentrations, with the largest decreases in SM, PI and PE.
[3H]PC increased 33% with increasing [Mg2]o, whereas
[3H]SM and [3H]PE increased by 390 and 220%, respectively.
The 8-fold increase in PI 3H-labeling with increased [Mg2]o
(to 4.8 mM) may re£ect changes in a minor PI component
and not be indicative of changes in the total PI pool.
Clearly, a variation in intracellular free Mg2 has a greater
e¡ect on SM turnover than on turnover of any of the other
major membrane phospholipids (PC, PE) (Table 1). Since SM
is synthesized at the expense of PC, the PC/SM ratio was
calculated from Table 1. Fig. 2 illustrates the [3H]PC/
[3H]SM and the [3H]PC/[3H]PE ratios over a range of
FEBS 21199 30-11-98
Fig. 2. Left hand ordinate: Changes in PC/SM and PC/PE ratios in
[3H]palmitic acid-labeled rat aortic cells as a function of [Mg2]o.
Values shown are calculated from the data shown in Table 1. Right
hand ordinate: Change in total phospholipid content of rat aortic
cells as a function of [Mg2]o. Total phospholipid content of tripli-
cate samples was determined by 1H-NMR at 3.99 ppm as described
in Section 2. Vertical dotted and solid lines indicate human serum
ionized Mg2 ranges: from left to right, pathological (0.3^0.54
mM), normal (0.55^0.65 mM), and after Mg2 therapy (1.2^4.8
mM).
Fig. 1. A and B: Changes in [3H]phosphatidylcholine (PC) in dog
cerebral blood vessel segments as a function of time after transfer
to Krebs-Ringer bicarbonate (KRB) medium containing 0.17 or 1.2
mM Mg2 (A). Segments pooled from 4 dogs were preincubated in
normal KRB containing [3H]palmitic acid and 0.6 mM ionized
Mg2 for 3 h at 37‡C. Segments were then rinsed with fresh normal
KRB, transferred to KRB containing low (0.17 mM) or high (1.2
mM) Mg2 and extracted at the times indicated. B: Changes in
[3H]sphingomyelin (SM) in dog cerebral blood vessel segments as a
function of time after transfer to Krebs-Ringer bicarbonate (KRB)
medium containing 0.17 or 1.2 mM Mg2. Values were obtained
from analysis of the samples described in Section 2. For details see
Section 2. N = 6.
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[Mg2]o. When the [3H]PC/[3H]SM ratios are plotted as a
function of [Mg2]o, it can be seen that the ratio of labeled
PC/SM in vascular smooth muscle cells increased from about
17:1 at the lowest [Mg2]o to about 52:1 at the highest ex-
tracellular Mg2 ion concentration. For comparison, the PC/
[3H]PE ratio rose only from about 11:1 to 18:1. The solid
vertical lines indicate the rather narrow range for normal ex-
tracellular ionized Mg2 (0.55^0.65 mM). The vertical dotted
line at 0.3 mM indicates the lowest reported serum ionized
Mg2 concentration in patients, whereas that at 4.8 mM in-
dicates the upper limit reported in patients after Mg2 therapy
[9]. It can be seen that the greatest change in the PC/SM ratio
occurred within the range observed in patients with hypomag-
nesemia.
Total phospholipid was measured in crude lipid extracts of
rat aorta and dog cerebrovascular tissue using 1H-NMR tech-
niques. The protons at the C3 position of glycerol in phos-
pholipids appear as a multiplet at 3.99 ppm [25] and can be
used to quantitate total phospholipid in either crude extracts
or aminopropylsilyl column fractions. As shown in Fig. 2, the
total phospholipid content of aortic smooth muscle cells in-
creased less than 5% with increasing [Mg2]o. Similarly, no
marked change in total phospholipid was detected in total
lipid extracts of dog cerebral blood vessel smooth muscle tis-
sue (data not shown).
3.3. Prolonged exposure to elevated or lowered [Mg2+]o leads
to reciprocal changes in 1,2-DAG and ceramide levels in
vascular smooth muscle cells
Ceramide and 1,2-DAG pools were measured in rat aortic
smooth muscle cells labeled with [3H]palmitic acid following
an 18-h incubation in NKRB media containing 0.17, 0.3, 0.6
or 1.2 mM [Mg2]o. As [Mg2]o was decreased, [3H]ceramide
levels increased sharply with a concomitant fall in 1,2-DAG,
showing a reciprocal relationship between DAG and ceramide
levels (Fig. 3). Since PC and ceramide undergo an exchange
reaction (via SM synthase) to form 1,2-DAG and SM, the
changes in ceramide and 1,2-DAG levels, together with the
drop in SM, indicate that a reduction in ionized Mg2 may
inhibit SM synthase activity in smooth muscle.
4. Discussion
Our data directly indicate that the incorporation and turn-
over of palmitate radioactivity into lipids is clearly [Mg2]o
dependent. Our in vitro studies with aortic and cerebrovascu-
lar smooth muscle show that reduction in [Mg2]o below the
normal serum value of 0.6 mM down-regulates synthesis of
some of the key phospholipids. The decrease in PC, the major
glycerophospholipid, is, however, small compared to that of
SM, the major sphingophospholipid. The ratio of PC to SM
nearly doubles as [Mg2]o is reduced from 0.6 mM to 0.3 mM
(Fig. 2), the latter occurring in the serum of patients with
hypomagnesemia. These samples also show a small but sig-
ni¢cant rise in ceramide, and a reciprocal drop in 1,2-DAG
(Fig. 3). Since SM is synthesized by a transfer reaction be-
tween ceramide and PC (thereby releasing 1,2-DAG), and
since 1,2-DAG does not increase, but ceramide does, it ap-
pears that low [Mg2]o somehow results in down-regulation of
SM synthase activity. In contrast, increasing [Mg2]o within
the range observed in patients after therapeutic administration
of Mg salts caused only a slight reduction in the PC/SM ratio,
but a large reduction in ceramide and an increase in 1,2-DAG
(Fig. 2).
There are several possible consequences of a reduction in
SM. Most SM is con¢ned to the plasma membrane [16],
where it is a source of lipid-derived second messengers. Li-
gands which bind to receptors for tumor necrosis factor K
(TNF-K), interleukin-1, Fas, and interferon-Q are among the
intracellular activators of SMase [26,27]. The ceramide gener-
ated may either accumulate or be further metabolized to
sphingosine or sphingosine-1-phosphate, which have also
been proposed as lipid mediators (reviewed in [27]). Many
e¡ects of ligand binding to these receptors have been dupli-
cated using short chain cell-permeable ceramides. Ceramide
and its downstream products activate di¡erent serine/threo-
nine protein kinase cascades and protein phosphatases which
regulate the function of several transcription factors, such as
NF-UB, which coordinately control genes encoding in£amma-
tory cytokines and cell adhesion molecules. Ceramide-acti-
vated protein kinase initiates pro-in£ammatory activity in re-
sponse to TNF-K stimulation, probably by phosphorylating
and activating Raf-1. The multiple e¡ects of ceramide (re-
viewed in [26,27]) suggest that it mediates a variety of cell
responses to stress, initiated by signals from di¡erent plasma
membrane receptors. In a preliminary report we described a
linear increase in the p65 subunit of NF-UB when cell cultures
of aortic vascular smooth muscle were incubated with decreas-
ing [Mg2]o [28]. We presume that this was due not to recep-
tor activation but to the increased intracellular ceramide and/
or its downstream products. If low [Mg2]o does in fact pro-
mote the transcription of in£ammatory proteins and adhesion
molecules [29], it could be a contributing factor in atherogen-
esis, which has in£ammatory and leukocyte components.
We have previously reported that low [Mg2]o led to in-
creased fatty acid saturation and plasmalogen (K,L-unsatu-
rated ether) content as well as to a decreased average fatty
acid chain length in vascular smooth muscle cells [15]. The
alterations in phospholipid composition and lipid second mes-
sengers may be relevant to the increased contractility [7,8] and
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Fig. 3. Changes in [3H]ceramide and 1,2-[3H]diacylglycerol (1,2-
DAG) in [3H]palmitic acid-labeled rat aortic cells as a function of
[Mg2]o. Values are from the experiment described in Table 1.
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changes in Ca2 permeability [20,30] that are known to occur
in low extracellular Mg2. Taken in toto, extracellular Mg2
appears to modulate the basal levels of at least two lipid
messengers as well as SM synthesis, fatty acid saturation
and the acyl ether content of di¡erent types of the membrane
phospholipids of vascular smooth muscle cells.
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